| Sr No. |
|
Additional disclosure of related
party transactions - applicable only in case the related party transaction relates to loans,
inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary.
These details need to be disclosed only once, during the reporting period when such transaction was
undertaken. |
| Details of the party (listed entity/subsidiary) entering into the transaction |
Details of the counterparty |
Type of related party transaction |
Details of other related party transaction |
Value of the related party transaction as approved by the audit committee |
Remarks on approval by audit committee |
Value of the related party transaction ratified by the audit committee |
Date of Audit Committee Meeting where the ratification was approved |
Value of transaction during the reporting period |
In case monies are due to either party as a result of the transaction |
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments |
Details of the loans, inter-corporate deposits, advances or investments |
Notes |
| Name |
PAN |
Name |
PAN |
Relationship of the counterparty with the listed entity or its subsidiary |
Opening balance |
Closing balance |
Nature of indebtedness (loan/ issuance of debt/ any other etc.) |
Details of other indebtedness |
Cost |
Tenure |
Nature (loan/ advance/ intercorporate deposit/ investment ) |
Interest Rate (%) |
Tenure |
Secured/ unsecured |
Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
| 1 |
Strides Consumer Pvt Ltd |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
157.80 |
11,293.40 |
|
|
|
|
|
|
|
|
|
|
| 2 |
Strides Consumer Pvt Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
148.00 |
7,891.30 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Arco Lab Private Limited |
|
Aurore Life Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
36.90 |
38.40 |
|
|
|
|
|
|
|
|
|
|
| 4 |
Arco Lab Private Limited |
|
Aurore Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
38.90 |
52.00 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Arco Lab Private Limited |
|
Brooks Steriscience Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
66.20 |
13.20 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Arco Lab Private Limited |
|
Hydra Active Pharma Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
17.60 |
12.50 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Arco Lab Private Limited |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
538.50 |
544.80 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Arco Lab Private Limited |
|
Naari Pharma Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
68.30 |
55.90 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Arco Lab Private Limited |
|
Neviton Softech Private Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
444.90 |
660.80 |
|
|
|
|
|
|
|
|
|
|
| 10 |
Arco Lab Private Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
10.10 |
|
|
|
|
|
|
|
|
|
|
| 11 |
Arco Lab Private Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,080.50 |
7,843.30 |
|
|
|
|
|
|
|
|
|
|
| 12 |
Arco Lab Private Limited |
|
Serovia Usa Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.10 |
1.10 |
|
|
|
|
|
|
|
|
|
|
| 13 |
Arco Lab Private Limited |
|
Six Rays LLP |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
11.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 14 |
Arco Lab Private Limited |
|
Six Rays Pharma Solutions Llp |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
9.40 |
11.70 |
|
|
|
|
|
|
|
|
|
|
| 15 |
Arco Lab Private Limited |
|
Six Rays Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.40 |
0.60 |
|
|
|
|
|
|
|
|
|
|
| 16 |
Arco Lab Private Limited |
|
Sixrays Holdings Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.10 |
0.60 |
|
|
|
|
|
|
|
|
|
|
| 17 |
Arco Lab Private Limited |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
697.90 |
427.60 |
|
|
|
|
|
|
|
|
|
|
| 18 |
Arco Lab Private Limited |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
289.70 |
34.90 |
|
|
|
|
|
|
|
|
|
|
| 19 |
Arco Lab Private Limited |
|
Steriscience Spolka Z |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
107.10 |
179.10 |
|
|
|
|
|
|
|
|
|
|
| 20 |
Arco Lab Private Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.30 |
0.30 |
|
|
|
|
|
|
|
|
|
|
| 21 |
Arco Lab Private Limited |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.30 |
10.30 |
|
|
|
|
|
|
|
|
|
|
| 22 |
Arco Lab Private Limited |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
53.60 |
7.60 |
|
|
|
|
|
|
|
|
|
|
| 23 |
Arco Lab Private Limited |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.50 |
8.40 |
|
|
|
|
|
|
|
|
|
|
| 24 |
Arco Lab Private Limited |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.20 |
|
|
|
|
|
|
|
|
|
|
| 25 |
Arco Lab Private Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.80 |
22.30 |
|
|
|
|
|
|
|
|
|
|
| 26 |
Arco Lab Private Limited |
|
Strides Pharma Asia Pte Ltd |
|
Subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.30 |
|
|
|
|
|
|
|
|
|
|
| 27 |
Arco Lab Private Limited |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.90 |
38.70 |
|
|
|
|
|
|
|
|
|
|
| 28 |
Arco Lab Private Limited |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
3.80 |
|
|
|
|
|
|
|
|
|
|
| 29 |
Arco Lab Private Limited |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.00 |
1.30 |
|
|
|
|
|
|
|
|
|
|
| 30 |
Arco Lab Private Limited |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
1.20 |
|
|
|
|
|
|
|
|
|
|
| 31 |
Arco Lab Private Limited |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
8.70 |
18.70 |
|
|
|
|
|
|
|
|
|
|
| 32 |
Arco Lab Private Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
5.20 |
9.30 |
|
|
|
|
|
|
|
|
|
|
| 33 |
Arco Lab Private Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
40.60 |
33.40 |
|
|
|
|
|
|
|
|
|
|
| 34 |
Arco Lab Private Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
121.60 |
4.60 |
|
|
|
|
|
|
|
|
|
|
| 35 |
Arco Lab Private Limited |
|
Strides Pharma International Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.80 |
1.00 |
|
|
|
|
|
|
|
|
|
|
| 36 |
Arco Lab Private Limited |
|
Strides Pharma Science Pty Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.60 |
2.60 |
|
|
|
|
|
|
|
|
|
|
| 37 |
Arco Lab Private Limited |
|
Strides Pharma Services Private limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.40 |
1.90 |
|
|
|
|
|
|
|
|
|
|
| 38 |
Arco Lab Private Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
14.40 |
6.30 |
|
|
|
|
|
|
|
|
|
|
| 39 |
Arco Lab Private Limited |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.00 |
1.50 |
|
|
|
|
|
|
|
|
|
|
| 40 |
Arco Lab Private Limited |
|
Tenshi Healthcare Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.10 |
1.10 |
|
|
|
|
|
|
|
|
|
|
| 41 |
Arco Lab Private Limited |
|
Tenshi Kaizen B.V. |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.70 |
6.30 |
|
|
|
|
|
|
|
|
|
|
| 42 |
Arco Lab Private Limited |
|
Tenshi Kaizen Inc. |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.10 |
3.30 |
|
|
|
|
|
|
|
|
|
|
| 43 |
Arco Lab Private Limited |
|
Tenshi Kaizen Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.10 |
1.10 |
|
|
|
|
|
|
|
|
|
|
| 44 |
Arco Lab Private Limited |
|
Tenshi Kaizen Uk Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.80 |
4.50 |
|
|
|
|
|
|
|
|
|
|
| 45 |
Arco Lab Private Limited |
|
Tenshi Life Sciences Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(0.50) |
0.60 |
|
|
|
|
|
|
|
|
|
|
| 46 |
Arco Lab Private Limited |
|
Tenshi Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
67.90 |
98.60 |
|
|
|
|
|
|
|
|
|
|
| 47 |
Arco Lab Private Limited |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.30 |
4.50 |
|
|
|
|
|
|
|
|
|
|
| 48 |
Arco Lab Private Limited |
|
Universal Corporation Limited |
|
Associate |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.00 |
11.40 |
|
|
|
|
|
|
|
|
|
|
| 49 |
Arco Lab Private Limited |
|
Velbiom Probiotics Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
14.30 |
11.50 |
|
|
|
|
|
|
|
|
|
|
| 50 |
Arco Lab Private Limited |
|
Y Usha Rani |
|
Relative of promoters'/ promoters' group |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.90 |
1.90 |
|
|
|
|
|
|
|
|
|
|
| 51 |
Fairmed Healthcare GmbH |
|
Brooks Steriscience Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
3.00 |
|
|
|
|
|
|
|
|
|
|
| 52 |
Fairmed Healthcare GmbH |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
22.20 |
22.60 |
|
|
|
|
|
|
|
|
|
|
| 53 |
Fairmed Healthcare GmbH |
|
Naari Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
9.60 |
10.90 |
|
|
|
|
|
|
|
|
|
|
| 54 |
Fairmed Healthcare GmbH |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
23.00 |
1.30 |
|
|
|
|
|
|
|
|
|
|
| 55 |
Fairmed Healthcare GmbH |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.60 |
1.80 |
|
|
|
|
|
|
|
|
|
|
| 56 |
Fairmed Healthcare GmbH |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.40 |
76.80 |
|
|
|
|
|
|
|
|
|
|
| 57 |
Fairmed Healthcare GmbH |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,668.10 |
4,520.00 |
|
|
|
|
|
|
|
|
|
|
| 58 |
Fairmed Healthcare GmbH |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
1.10 |
|
|
|
|
|
|
|
|
|
|
| 59 |
Neviton Technologies Inc., |
|
Neviton Softech Private Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(186.00) |
287.40 |
|
|
|
|
|
|
|
|
|
|
| 60 |
Strides Arcolab International Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2,051.20 |
3,297.50 |
|
|
|
|
|
|
|
|
|
|
| 61 |
Strides Arcolab International Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.50 |
|
|
|
|
|
|
|
|
|
|
| 62 |
Strides Consumer Llc |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(0.10) |
(38.20) |
|
|
|
|
|
|
|
|
|
|
| 63 |
Strides Global Consumer Healthcare Limited |
|
Strides Pharma Science Pty Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.30 |
1.00 |
|
|
|
|
|
|
|
|
|
|
| 64 |
Strides Global Consumer Healthcare Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.50 |
|
|
|
|
|
|
|
|
|
|
| 65 |
Strides Global Consumer Healthcare Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
1.40 |
|
|
|
|
|
|
|
|
|
|
| 66 |
Strides Global Consumer Healthcare Limited |
|
Wabisabi Advisory Llp |
|
Related party of subsidiary |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
35.00 |
|
|
|
|
|
|
|
|
|
|
| 67 |
Strides Pharma (Cyprus) Limited |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
20.10 |
|
|
|
|
|
|
|
|
|
|
| 68 |
Strides Pharma (Cyprus) Limited |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2,928.00 |
2,605.70 |
|
|
|
|
|
|
|
|
|
|
| 69 |
Strides Pharma (Cyprus) Limited |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,133.20 |
68.90 |
|
|
|
|
|
|
|
|
|
|
| 70 |
Strides Pharma (Cyprus) Limited |
|
UCL Brands Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(284.30) |
251.80 |
|
|
|
|
|
|
|
|
|
|
| 71 |
Strides Pharma (SA) (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(364.30) |
(481.10) |
|
|
|
|
|
|
|
|
|
|
| 72 |
Strides Pharma (SA) (Pty) Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
(146.20) |
|
|
|
|
|
|
|
|
|
|
| 73 |
Strides Pharma (SA) (Pty) Ltd |
|
The Vaccine Bureau (Pty) Ltd |
|
Related party of subsidiary |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(107.00) |
(122.50) |
|
|
|
|
|
|
|
|
|
|
| 74 |
Strides Pharma Asia Pte Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
310.40 |
20.50 |
|
|
|
|
|
|
|
|
|
|
| 75 |
Strides Pharma Canada Inc. |
|
Pharmapar Inc |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,759.90 |
1,264.60 |
|
|
|
|
|
|
|
|
|
|
| 76 |
Strides Pharma Canada Inc. |
|
Pharmapar Inc |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.60 |
2.80 |
|
|
|
|
|
|
|
|
|
|
| 77 |
Strides Pharma Global (UK) Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
117.80 |
994.20 |
|
|
|
|
|
|
|
|
|
|
| 78 |
Strides Pharma Global (UK) Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
151.40 |
149.10 |
|
|
|
|
|
|
|
|
|
|
| 79 |
Strides Pharma Global Pte Limited |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(1.20) |
(38.70) |
|
|
|
|
|
|
|
|
|
|
| 80 |
Strides Pharma Global Pte Limited |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
11,629.80 |
16,160.50 |
|
|
|
|
|
|
|
|
|
|
| 81 |
Strides Pharma Global Pte Limited |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(138.40) |
(183.20) |
|
|
|
|
|
|
|
|
|
|
| 82 |
Strides Pharma Global Pte Limited |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
32.00 |
|
|
|
|
|
|
|
|
|
|
| 83 |
Strides Pharma Global Pte Limited |
|
Naari Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
40.10 |
41.70 |
|
|
|
|
|
|
|
|
|
|
| 84 |
Strides Pharma Global Pte Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
92.40 |
|
|
|
|
|
|
|
|
|
|
| 85 |
Strides Pharma Global Pte Limited |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
247.70 |
|
|
|
|
|
|
|
|
|
|
| 86 |
Strides Pharma Global Pte Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
52,438.10 |
59,203.20 |
|
|
|
|
|
|
|
|
|
|
| 87 |
Strides Pharma Global Pte Limited |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2,931.30 |
2,034.60 |
|
|
|
|
|
|
|
|
|
|
| 88 |
Strides Pharma Global Pte Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
96.50 |
74.40 |
|
|
|
|
|
|
|
|
|
|
| 89 |
Strides Pharma Global Pte Limited |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
847.00 |
838.80 |
|
|
|
|
|
|
|
|
|
|
| 90 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 91 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
88,328.20 |
52,352.80 |
|
|
|
|
|
|
|
|
|
|
| 92 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
8,133.00 |
15,391.00 |
|
|
|
|
|
|
|
|
|
|
| 93 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
14,397.30 |
18,690.00 |
|
|
|
|
|
|
|
|
|
|
| 94 |
Strides Pharma Global Pte Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
4,857.60 |
5,219.70 |
|
|
|
|
|
|
|
|
|
|
| 95 |
Strides Pharma Global Pte Limited |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
(17,892.10) |
|
|
|
|
|
|
|
|
|
|
| 96 |
Strides Pharma Global Pte Limited |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
88.90 |
75.00 |
|
|
|
|
|
|
|
|
|
|
| 97 |
Strides Pharma Global Pte Limited |
|
Universal Corporation Limited |
|
Associate |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(278.10) |
1,454.90 |
|
|
|
|
|
|
|
|
|
|
| 98 |
Strides Pharma Inc |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
22.20 |
|
|
|
|
|
|
|
|
|
|
| 99 |
Strides Pharma Inc |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
512.60 |
9,759.40 |
|
|
|
|
|
|
|
|
|
|
| 100 |
Strides Pharma Inc |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
512.60 |
131.40 |
|
|
|
|
|
|
|
|
|
|
| 101 |
Strides Pharma Inc |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,162.10 |
748.30 |
|
|
|
|
|
|
|
|
|
|
| 102 |
Strides Pharma Inc |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
21.60 |
|
|
|
|
|
|
|
|
|
|
| 103 |
Strides Pharma Inc |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3,244.20 |
9,971.60 |
|
|
|
|
|
|
|
|
|
|
| 104 |
Strides Pharma Inc |
|
Whitecrow Research, Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
6.20 |
|
|
|
|
|
|
|
|
|
|
| 105 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
5,693.70 |
222.00 |
|
|
|
|
|
|
|
|
|
|
| 106 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(27.40) |
425.10 |
|
|
|
|
|
|
|
|
|
|
| 107 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
11,574.90 |
15,259.30 |
|
|
|
|
|
|
|
|
|
|
| 108 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Naari Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
23.00 |
25.90 |
|
|
|
|
|
|
|
|
|
|
| 109 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
563.50 |
589.90 |
|
|
|
|
|
|
|
|
|
|
| 110 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
29.40 |
|
|
|
|
|
|
|
|
|
|
| 111 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Six Rays Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
13.40 |
|
|
|
|
|
|
|
|
|
|
| 112 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
9.30 |
18.60 |
|
|
|
|
|
|
|
|
|
|
| 113 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
25.70 |
|
|
|
|
|
|
|
|
|
|
| 114 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
9.10 |
|
|
|
|
|
|
|
|
|
|
| 115 |
Strides Pharma International Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
12,373.10 |
(88.80) |
|
|
|
|
|
|
|
|
|
|
| 116 |
Strides Pharma Science Ltd |
|
Arco Lab Private Limited |
|
Subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,449.60 |
1,459.80 |
|
|
|
|
|
|
|
|
|
|
| 117 |
Strides Pharma Science Ltd |
|
Arco Lab Private Limited |
|
Subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
24.80 |
85.50 |
|
|
|
|
|
|
|
|
|
|
| 118 |
Strides Pharma Science Ltd |
|
Aurore Life Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,682.00 |
735.30 |
|
|
|
|
|
|
|
|
|
|
| 119 |
Strides Pharma Science Ltd |
|
Aurore Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
12.80 |
16.70 |
|
|
|
|
|
|
|
|
|
|
| 120 |
Strides Pharma Science Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
(11.40) |
|
|
|
|
|
|
|
|
|
|
| 121 |
Strides Pharma Science Ltd |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,357.50 |
663.50 |
|
|
|
|
|
|
|
|
|
|
| 122 |
Strides Pharma Science Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
44.00 |
(109.80) |
|
|
|
|
|
|
|
|
|
|
| 123 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
9.00 |
637.50 |
|
|
|
|
|
|
|
|
|
|
| 124 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
11,764.50 |
17,465.00 |
|
|
|
|
|
|
|
|
|
|
| 125 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
69.50 |
51.60 |
|
|
|
|
|
|
|
|
|
|
| 126 |
Strides Pharma Science Ltd |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.30 |
2.40 |
|
|
|
|
|
|
|
|
|
|
| 127 |
Strides Pharma Science Ltd |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
258.50 |
62.70 |
|
|
|
|
|
|
|
|
|
|
| 128 |
Strides Pharma Science Ltd |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
6.40 |
6.70 |
|
|
|
|
|
|
|
|
|
|
| 129 |
Strides Pharma Science Ltd |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
440.70 |
456.70 |
|
|
|
|
|
|
|
|
|
|
| 130 |
Strides Pharma Science Ltd |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
15.10 |
15.10 |
|
|
|
|
|
|
|
|
|
|
| 131 |
Strides Pharma Science Ltd |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
256.30 |
256.50 |
|
|
|
|
|
|
|
|
|
|
| 132 |
Strides Pharma Science Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
6.40 |
6.70 |
|
|
|
|
|
|
|
|
|
|
| 133 |
Strides Pharma Science Ltd |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2.40 |
2.50 |
|
|
|
|
|
|
|
|
|
|
| 134 |
Strides Pharma Science Ltd |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
42.00 |
47.40 |
|
|
|
|
|
|
|
|
|
|
| 135 |
Strides Pharma Science Ltd |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
374.70 |
354.40 |
|
|
|
|
|
|
|
|
|
|
| 136 |
Strides Pharma Science Ltd |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
32.40 |
36.60 |
|
|
|
|
|
|
|
|
|
|
| 137 |
Strides Pharma Science Ltd |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
7.10 |
(5.40) |
|
|
|
|
|
|
|
|
|
|
| 138 |
Strides Pharma Science Ltd |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
93.10 |
539.00 |
|
|
|
|
|
|
|
|
|
|
| 139 |
Strides Pharma Science Ltd |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
201.90 |
340.30 |
|
|
|
|
|
|
|
|
|
|
| 140 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
388.10 |
29.10 |
|
|
|
|
|
|
|
|
|
|
| 141 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,28,902.20 |
1,12,045.90 |
|
|
|
|
|
|
|
|
|
|
| 142 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
595.70 |
722.50 |
|
|
|
|
|
|
|
|
|
|
| 143 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
550.80 |
811.40 |
|
|
|
|
|
|
|
|
|
|
| 144 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
172.90 |
|
|
|
|
|
|
|
|
|
|
| 145 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
5,678.80 |
15,269.80 |
|
|
|
|
|
|
|
|
|
|
| 146 |
Strides Pharma Science Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
777.20 |
30.90 |
|
|
|
|
|
|
|
|
|
|
| 147 |
Strides Pharma Science Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2,758.20 |
4,672.30 |
|
|
|
|
|
|
|
|
|
|
| 148 |
Strides Pharma Science Ltd |
|
Tenshi Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
12.10 |
0.30 |
|
|
|
|
|
|
|
|
|
|
| 149 |
Strides Pharma Science Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
5.60 |
5.80 |
|
|
|
|
|
|
|
|
|
|
| 150 |
Strides Pharma Science Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
15.80 |
|
|
|
|
|
|
|
|
|
|
| 151 |
Strides Pharma Science Ltd |
|
Universal Corporation Limited |
|
Associate |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
(187.60) |
|
|
|
|
|
|
|
|
|
|
| 152 |
Strides Pharma Science Ltd |
|
Universal Corporation Limited |
|
Associate |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
41.80 |
183.70 |
|
|
|
|
|
|
|
|
|
|
| 153 |
Strides Pharma Science Pty Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.90 |
2.00 |
|
|
|
|
|
|
|
|
|
|
| 154 |
Strides Pharma UK Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.40 |
(88.20) |
|
|
|
|
|
|
|
|
|
|
| 155 |
Strides Pharma UK Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
218.40 |
4.50 |
|
|
|
|
|
|
|
|
|
|
| 156 |
Strides Pharma UK Ltd |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
8.60 |
(44.40) |
|
|
|
|
|
|
|
|
|
|
| 157 |
Strides Pharma UK Ltd |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(1.50) |
159.30 |
|
|
|
|
|
|
|
|
|
|
| 158 |
Strides Pharma UK Ltd |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.40 |
|
|
|
|
|
|
|
|
|
|
| 159 |
Strides Pharma UK Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(0.40) |
127.10 |
|
|
|
|
|
|
|
|
|
|
| 160 |
SVADS Holdings SA |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
5,837.20 |
87.20 |
|
|
|
|
|
|
|
|
|
|
| 161 |
Trinity Pharma (Pty) Ltd |
|
Kahma Healthcare Group (Pty) Ltd |
|
Related party of subsidiary |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.70 |
(2.00) |
|
|
|
|
|
|
|
|
|
|
| 162 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(173.00) |
564.70 |
|
|
|
|
|
|
|
|
|
|
| 163 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.70 |
(38.00) |
|
|
|
|
|
|
|
|
|
|
| 164 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
16.90 |
8.60 |
|
|
|
|
|
|
|
|
|
|
| 165 |
Trinity Pharma (Pty) Ltd |
|
K2 Medical (Pty) Ltd |
|
Related party of subsidiary |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 166 |
Trinity Pharma (Pty) Ltd |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
2,125.80 |
1,092.50 |
|
|
|
|
|
|
|
|
|
|
| 167 |
Trinity Pharma (Pty) Ltd |
|
The Vaccine Bureau (Pty) Ltd |
|
Related party of subsidiary |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
4.40 |
(5.90) |
|
|
|
|
|
|
|
|
|
|
| 168 |
Arco Lab Private Limited |
|
Agnus Capital LLP |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 169 |
Arco Lab Private Limited |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
22.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 170 |
Arco Lab Private Limited |
|
Biolexis Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
42.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 171 |
Arco Lab Private Limited |
|
Biolexis Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 172 |
Arco Lab Private Limited |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
489.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 173 |
Arco Lab Private Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
14.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 174 |
Fairmed Healthcare GmbH |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 175 |
Strides Consumer Pvt Ltd |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(3.90) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 176 |
Strides Consumer Pvt Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(5.70) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 177 |
Strides Pharma (Cyprus) Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
86.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 178 |
Strides Pharma (Cyprus) Limited |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
85.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 179 |
Strides Pharma (Cyprus) Limited |
|
UCL Brands Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(284.30) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 180 |
Strides Pharma (Cyprus) Limited |
|
Universal Corporation Limited |
|
Associate |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(0.90) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 181 |
Strides Pharma Inc |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
7,828.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 182 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(9.70) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 183 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
78.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 184 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
65.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 185 |
Strides Pharma Science Ltd |
|
Atma Projects |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
47.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 186 |
Strides Pharma Science Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
18.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 187 |
Strides Pharma Science Ltd |
|
Chayadeep Properties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
15.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 188 |
Strides Pharma Science Ltd |
|
Juno OTC INC |
|
Related party of subsidiary |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
80.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 189 |
Strides Pharma Science Ltd |
|
Naari Pharma Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 190 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
347.10 |
5,897.40 |
|
|
|
|
|
|
|
|
|
|
| 191 |
Strides Pharma Science Ltd |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
151.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 192 |
Strides Pharma Canada Inc. |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
145.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 193 |
Strides Netherlands B.V. |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
85.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 194 |
Strides Nordic ApS, |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
173.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 195 |
Strides Pharma (SA) (Pty) Ltd |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
165.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 196 |
SVADS Holdings SA |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
11.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 197 |
Trinity Pharma (Pty) Ltd |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
902.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 198 |
Trinity Pharma (Pty) Ltd |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 199 |
Trinity Pharma (Pty) Ltd |
|
Asaco Trinity (Pty) Ltd |
|
Related party of subsidiary |
Loan |
|
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(124.00) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 200 |
Arco Lab Private Limited |
|
Neviton Softech Private Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
1,200.00 |
NA |
348.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 201 |
Fairmed Healthcare GmbH |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
5,509.90 |
NA |
3,400.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 202 |
Neviton Softech Private Limited |
|
Neviton Technologies Inc., |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
740.00 |
NA |
220.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 203 |
Strides Arcolab International Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Interest received |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
107.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(1) |
| 204 |
Strides Arcolab International Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
563.70 |
0.00 |
0.00 |
|
|
|
|
Loan |
6.6600 |
1 Year |
Unsecured |
For business purpose |
Textual Information(2) |
| 205 |
Strides Arcolab International Ltd |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Investment |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
2,497.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(3) |
| 206 |
Strides Arcolab International Ltd |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Interest received |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
181.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(4) |
| 207 |
Strides Consumer Llc |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
2,515.20 |
NA |
178.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 208 |
Strides Pharma (Cyprus) Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
72.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 209 |
Strides Pharma (Cyprus) Limited |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
91.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(5) |
| 210 |
Strides Pharma (Cyprus) Limited |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Interest received |
|
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
49.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 211 |
Strides Pharma (SA) (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Interest paid |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
18.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 212 |
Strides Pharma (SA) (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Loan |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
56.10 |
0.00 |
0.00 |
|
|
|
|
Loan |
11.2500 |
3 Years |
Unsecured |
For business purpose |
|
| 213 |
Strides Pharma (SA) (Pty) Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
141.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 214 |
Strides Pharma (SA) (Pty) Ltd |
|
The Vaccine Bureau (Pty) Ltd |
|
Related party of subsidiary |
Interest paid |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
4.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 215 |
Strides Pharma (SA) (Pty) Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Interest paid |
|
485.00 |
NA |
81.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 216 |
Strides Pharma (SA) (Pty) Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
7,275.00 |
NA |
1,181.60 |
0.00 |
0.00 |
|
|
|
|
Loan |
11.2500 |
3 Years |
Unsecured |
For business purpose |
|
| 217 |
Strides Pharma (SA) (Pty) Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
4,850.00 |
NA |
1,176.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 218 |
Strides Pharma Asia Pte Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Interest received |
|
41.60 |
NA |
11.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 219 |
Strides Pharma Canada Inc. |
|
Juno Otc Inc.,Canada |
|
Related party of subsidiary |
Sale of goods or services |
|
730.60 |
NA |
94.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 220 |
Strides Pharma Global (UK) Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Interest received |
|
58.30 |
NA |
12.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 221 |
Strides Pharma Global (UK) Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Investment |
|
4,664.80 |
NA |
902.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 222 |
Strides Pharma Global (UK) Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Loan |
|
2,449.00 |
NA |
968.40 |
0.00 |
0.00 |
|
|
|
|
Loan |
6.500 |
5 years |
Unsecured |
For business purpose |
|
| 223 |
Strides Pharma Global Pte Limited |
|
Amexel Pte. Ltd |
|
Step-down subsidiary of the listed entity |
Investment |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
43.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(6) |
| 224 |
Strides Pharma Global Pte Limited |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Interest received |
|
1,431.00 |
NA |
628.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 225 |
Strides Pharma Global Pte Limited |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of fixed assets |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
260.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 226 |
Strides Pharma Global Pte Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
134.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 227 |
Strides Pharma Global Pte Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Interest received |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
1,639.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(7) |
| 228 |
Strides Pharma Global Pte Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Loan |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
858.60 |
0.00 |
0.00 |
|
|
|
|
Loan |
8.500 |
5 years |
Unsecured |
For business purpose |
Textual Information(8) |
| 229 |
Strides Pharma Global Pte Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
2,683.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(9) |
| 230 |
Strides Pharma Global Pte Limited |
|
Strides Pharma (SA) (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
9,540.30 |
NA |
818.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 231 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Purchase of fixed assets |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
3,957.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(10) |
| 232 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
42,025.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(11) |
| 233 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Interest received |
|
2,289.70 |
NA |
581.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 234 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Loan |
|
13,323.90 |
NA |
5,102.30 |
0.00 |
0.00 |
|
|
|
|
Loan |
11.500 |
5 years |
Unsecured |
For business purpose |
|
| 235 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
1,734.60 |
NA |
11.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 236 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of fixed assets |
|
8,673.00 |
NA |
3,645.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 237 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
21,682.50 |
NA |
3,101.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 238 |
Strides Pharma Global Pte Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Interest received |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
253.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(12) |
| 239 |
Strides Pharma Global Pte Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Loan |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
1,592.80 |
0.00 |
0.00 |
|
|
|
|
Loan |
11.500 |
2 years |
Unsecured |
For business purpose |
Textual Information(13) |
| 240 |
Strides Pharma Global Pte Limited |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
8,673.00 |
NA |
(30.70) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 241 |
Strides Pharma Global Pte Limited |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
275.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 242 |
Strides Pharma Global Pte Limited |
|
Universal Corporation Limited |
|
Associate |
Purchase of goods or services |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
2,337.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 243 |
Strides Pharma Inc |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
30,355.50 |
NA |
10,586.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 244 |
Strides Pharma Inc |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
20,815.20 |
NA |
855.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 245 |
Strides Pharma Inc |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1,125.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 246 |
Strides Pharma Inc |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
21,682.50 |
NA |
9,536.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 247 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
2,604.70 |
NA |
67.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 248 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Interest received |
|
1,202.20 |
NA |
64.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 249 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
20,436.70 |
NA |
5,724.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 250 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
10,018.00 |
NA |
566.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 251 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
29.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 252 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
2,404.30 |
NA |
36.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 253 |
Strides Pharma Science Ltd |
|
Aurore Life Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
6,000.00 |
NA |
2,264.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 254 |
Strides Pharma Science Ltd |
|
Aurore Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
2,000.00 |
NA |
3.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 255 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
13,000.00 |
NA |
5,163.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 256 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of fixed assets |
|
1,200.00 |
NA |
21.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 257 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Sale of goods or services |
|
20,000.00 |
NA |
7,076.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 258 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Purchase of goods or services |
|
30,000.00 |
NA |
15,381.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 259 |
Strides Pharma Science Ltd |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Interest received |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
17.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(14) |
| 260 |
Strides Pharma Science Ltd |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
91.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(15) |
| 261 |
Strides Pharma Science Ltd |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
199.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(16) |
| 262 |
Strides Pharma Science Ltd |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
566.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(17) |
| 263 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
3.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(18) |
| 264 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
62,919.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(19) |
| 265 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
72.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(20) |
| 266 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
290.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(21) |
| 267 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
20,000.00 |
NA |
13,122.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 268 |
Strides Pharma Science Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
11,613.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(22) |
| 269 |
Strides Pharma Science Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Sale of goods or services |
|
2,000.00 |
NA |
15.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 270 |
Strides Pharma Science Ltd |
|
Universal Corporation Limited |
|
Associate |
Purchase of goods or services |
|
5,500.00 |
NA |
1,488.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 271 |
Strides Pharma UK Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
17,493.00 |
NA |
1,739.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 272 |
Strides Pharma UK Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Purchase of goods or services |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
21.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(23) |
| 273 |
SVADS Holdings SA |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Interest received |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
146.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(24) |
| 274 |
SVADS Holdings SA |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Loan |
|
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
17.40 |
0.00 |
0.00 |
|
|
|
|
Loan |
6.00 |
5 Years |
Unsecured |
For Business Purpose |
Textual Information(25) |
| 275 |
Trinity Pharma (Pty) Ltd |
|
Asaco Trinity (Pty) Ltd |
|
Related party of subsidiary |
Interest paid |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
4.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 276 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Interest paid |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
6.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 277 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Purchase of goods or services |
|
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
150.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 278 |
Strides Pharma Science Ltd |
|
Arun Kumar |
|
Key Managerial Personnel/ Director |
Remuneration |
|
320.20 |
NA |
320.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 279 |
Strides Pharma Science Ltd |
|
Aditya Kumar |
|
Key Managerial Personnel/ Director |
Remuneration |
|
131.10 |
NA |
131.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 280 |
Arco Lab Private Limited |
|
Aurore Life Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
6.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 281 |
Arco Lab Private Limited |
|
Aurore Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
21.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 282 |
Arco Lab Private Limited |
|
Brooks Steriscience Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
120.00 |
NA |
62.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 283 |
Arco Lab Private Limited |
|
Hydra Active Pharma Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
3.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 284 |
Arco Lab Private Limited |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
1,000.00 |
NA |
333.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 285 |
Arco Lab Private Limited |
|
Naari Pharma Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
900.00 |
NA |
195.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 286 |
Arco Lab Private Limited |
|
Neviton Softech Private Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
132.00 |
NA |
22.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 287 |
Arco Lab Private Limited |
|
Neviton Softech Private Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
300.00 |
NA |
22.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 288 |
Arco Lab Private Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
3,000.00 |
NA |
1,929.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 289 |
Arco Lab Private Limited |
|
Serovia Usa Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
10.00 |
NA |
2.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 290 |
Arco Lab Private Limited |
|
Six Rays LLP |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 291 |
Arco Lab Private Limited |
|
Six Rays Pharma Solutions Llp |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
2.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 292 |
Arco Lab Private Limited |
|
Six Rays Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 293 |
Arco Lab Private Limited |
|
Sixrays Holdings Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 294 |
Arco Lab Private Limited |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
1,700.00 |
NA |
434.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 295 |
Arco Lab Private Limited |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
1,200.00 |
NA |
122.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 296 |
Arco Lab Private Limited |
|
Steriscience Spolka Z |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
250.00 |
NA |
145.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 297 |
Arco Lab Private Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Support Service Income |
10.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(26) |
| 298 |
Arco Lab Private Limited |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
20.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(27) |
| 299 |
Arco Lab Private Limited |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
11.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(28) |
| 300 |
Arco Lab Private Limited |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
4.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(29) |
| 301 |
Arco Lab Private Limited |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
2.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(30) |
| 302 |
Arco Lab Private Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
21.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(31) |
| 303 |
Arco Lab Private Limited |
|
Strides Pharma Asia Pte Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(32) |
| 304 |
Arco Lab Private Limited |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(33) |
| 305 |
Arco Lab Private Limited |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
33.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(34) |
| 306 |
Arco Lab Private Limited |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
3.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(35) |
| 307 |
Arco Lab Private Limited |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(36) |
| 308 |
Arco Lab Private Limited |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
5.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(37) |
| 309 |
Arco Lab Private Limited |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
54.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(38) |
| 310 |
Arco Lab Private Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
3.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(39) |
| 311 |
Arco Lab Private Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
105.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(40) |
| 312 |
Arco Lab Private Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
30.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 313 |
Arco Lab Private Limited |
|
Strides Pharma International Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(41) |
| 314 |
Arco Lab Private Limited |
|
Strides Pharma Science Pty Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(42) |
| 315 |
Arco Lab Private Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
26.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(43) |
| 316 |
Arco Lab Private Limited |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
28.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(44) |
| 317 |
Arco Lab Private Limited |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(45) |
| 318 |
Arco Lab Private Limited |
|
Tenshi Healthcare Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 319 |
Arco Lab Private Limited |
|
Tenshi Kaizen B.V. |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
2.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 320 |
Arco Lab Private Limited |
|
Tenshi Kaizen Inc. |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 321 |
Arco Lab Private Limited |
|
Tenshi Kaizen Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 322 |
Arco Lab Private Limited |
|
Tenshi Kaizen Uk Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 323 |
Arco Lab Private Limited |
|
Tenshi Life Sciences Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 324 |
Arco Lab Private Limited |
|
Tenshi Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
600.00 |
NA |
160.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 325 |
Arco Lab Private Limited |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
7.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 326 |
Arco Lab Private Limited |
|
Universal Corporation Limited |
|
Associate |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
11.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 327 |
Arco Lab Private Limited |
|
Velbiom Probiotics Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
10.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 328 |
Arco Lab Private Limited |
|
Y Usha Rani |
|
Relative of promoters'/ promoters' group |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
8.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 329 |
Fairmed Healthcare GmbH |
|
Brooks Steriscience Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
102.30 |
NA |
4.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 330 |
Fairmed Healthcare GmbH |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
(0.90) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 331 |
Fairmed Healthcare GmbH |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
1,001.80 |
NA |
65.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 332 |
Fairmed Healthcare GmbH |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
116.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 333 |
Fairmed Healthcare GmbH |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
85.90 |
NA |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 334 |
Strides Arcolab International Ltd |
|
Dr. Kausalya Santhanam |
|
Key Managerial Personnel/ Director |
Any other transaction |
Directors Sitting Fee |
5.20 |
NA |
2.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 335 |
Strides Arcolab International Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(46) |
| 336 |
Strides Global Consumer Healthcare Limited |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Advance |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
199.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(47) |
| 337 |
Strides Global Consumer Healthcare Limited |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
1.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(48) |
| 338 |
Strides Global Consumer Healthcare Limited |
|
Wabisabi Advisory Llp |
|
Related party of subsidiary |
Any other transaction |
Reimbursement of Expenses incurred by |
102.00 |
NA |
18.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 339 |
Strides Global Consumer Healthcare Limited |
|
Wabisabi Advisory Llp |
|
Related party of subsidiary |
Any other transaction |
Support Service Expenses |
173.50 |
NA |
65.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 340 |
Strides Pharma (Cyprus) Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
119.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 341 |
Strides Pharma (Cyprus) Limited |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
41.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(49) |
| 342 |
Strides Pharma (Cyprus) Limited |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
28.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(50) |
| 343 |
Strides Pharma (SA) (Pty) Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
242.50 |
NA |
2.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 344 |
Strides Pharma Asia Pte Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantee Commission Income |
31.20 |
NA |
8.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 345 |
Strides Pharma Canada Inc. |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
361.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(51) |
| 346 |
Strides Pharma Global Pte Limited |
|
Amexel Pte. Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
2.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(52) |
| 347 |
Strides Pharma Global Pte Limited |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
119.30 |
NA |
36.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 348 |
Strides Pharma Global Pte Limited |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
1,248.90 |
NA |
124.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 349 |
Strides Pharma Global Pte Limited |
|
Brooks Steriscience Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
55.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 350 |
Strides Pharma Global Pte Limited |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
23.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 351 |
Strides Pharma Global Pte Limited |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
14.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 352 |
Strides Pharma Global Pte Limited |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
221.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 353 |
Strides Pharma Global Pte Limited |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
11.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(53) |
| 354 |
Strides Pharma Global Pte Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
226.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(54) |
| 355 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Capacity Reservation fees |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
10,765.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(55) |
| 356 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
245.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(56) |
| 357 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
42.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(57) |
| 358 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
572.40 |
NA |
4.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 359 |
Strides Pharma Global Pte Limited |
|
Strides Pharma New Zealand Pty Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
54.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(58) |
| 360 |
Strides Pharma Global Pte Limited |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
86.70 |
NA |
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 361 |
Strides Pharma Global Pte Limited |
|
Tenshi Life Sciences Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
317.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 362 |
Strides Pharma Inc |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
260.20 |
NA |
21.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 363 |
Strides Pharma Inc |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
33.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 364 |
Strides Pharma Inc |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
119.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 365 |
Strides Pharma Inc |
|
Naari Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 366 |
Strides Pharma Inc |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
260.20 |
NA |
90.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 367 |
Strides Pharma Inc |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
1,040.80 |
NA |
252.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 368 |
Strides Pharma Inc |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
52.00 |
NA |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 369 |
Strides Pharma Inc |
|
Serovia Usa Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
10.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 370 |
Strides Pharma Inc |
|
Serovia Usa Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
102.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 371 |
Strides Pharma Inc |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 372 |
Strides Pharma Inc |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
217.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 373 |
Strides Pharma Inc |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
1.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(59) |
| 374 |
Strides Pharma Inc |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
12.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(60) |
| 375 |
Strides Pharma Inc |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
67.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(61) |
| 376 |
Strides Pharma Inc |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
100.00 |
NA |
58.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 377 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
50.00 |
NA |
45.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 378 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
1,001.80 |
NA |
366.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 379 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
2,404.30 |
NA |
451.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 380 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
500.90 |
NA |
38.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 381 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
1,502.70 |
NA |
279.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 382 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Six Rays Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Rental Income |
100.00 |
NA |
0.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 383 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Six Rays Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
536.60 |
NA |
151.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 384 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
500.90 |
NA |
103.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 385 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
10.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 386 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transactions of subsidiaries within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
4.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 387 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
75.10 |
NA |
24.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 388 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
1,048.30 |
NA |
297.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 389 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
50.00 |
NA |
7.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 390 |
Strides Pharma Science Ltd |
|
Arco Lab Private Limited |
|
Subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
373.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(62) |
| 391 |
Strides Pharma Science Ltd |
|
Arco Lab Private Limited |
|
Subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
4,123.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(63) |
| 392 |
Strides Pharma Science Ltd |
|
Atma Projects |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Lease Payments |
1,500.00 |
NA |
561.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 393 |
Strides Pharma Science Ltd |
|
Aurore Life Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
100.00 |
NA |
11.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 394 |
Strides Pharma Science Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
120.00 |
NA |
(0.90) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 395 |
Strides Pharma Science Ltd |
|
Chayadeep Properties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Lease Payments |
600.00 |
NA |
173.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 396 |
Strides Pharma Science Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
250.00 |
NA |
110.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 397 |
Strides Pharma Science Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
250.00 |
NA |
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 398 |
Strides Pharma Science Ltd |
|
K.R. Anuradha |
|
Promoter Group |
Any other transaction |
Lease Payments |
360.00 |
NA |
128.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 399 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
1,000.00 |
NA |
440.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 400 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
3,000.00 |
NA |
821.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 401 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
1,000.00 |
NA |
75.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 402 |
Strides Pharma Science Ltd |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
600.00 |
NA |
0.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 403 |
Strides Pharma Science Ltd |
|
Steriscience Specialties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
600.00 |
NA |
109.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 404 |
Strides Pharma Science Ltd |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
0.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(64) |
| 405 |
Strides Pharma Science Ltd |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
8.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(65) |
| 406 |
Strides Pharma Science Ltd |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
226.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(66) |
| 407 |
Strides Pharma Science Ltd |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(67) |
| 408 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantee Commission Income |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
54.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(68) |
| 409 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
173.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(69) |
| 410 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
634.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(70) |
| 411 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
144.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(71) |
| 412 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
2.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(72) |
| 413 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
144.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(73) |
| 414 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Expenses |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
98.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(74) |
| 415 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
305.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(75) |
| 416 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
600.00 |
NA |
236.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 417 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
600.00 |
NA |
141.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 418 |
Strides Pharma Science Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
65.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(76) |
| 419 |
Strides Pharma Science Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Listed Entity and Its wholly owned Subsidiary-Exempt from Audit Committee Approval under SEBI LODR |
14.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(77) |
| 420 |
Strides Pharma Science Ltd |
|
Tenshi Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses incurred by |
100.00 |
NA |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 421 |
Strides Pharma Science Ltd |
|
Tenshi Pharmaceuticals Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
100.00 |
NA |
0.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 422 |
Strides Pharma Science Ltd |
|
Universal Corporation Limited |
|
Associate |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
500.00 |
NA |
94.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 423 |
Strides Pharma Science Ltd |
|
Universal Corporation Limited |
|
Associate |
Any other transaction |
Support Service Income |
1,500.00 |
NA |
87.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 424 |
Strides Pharma UK Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
17.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 425 |
Strides Pharma UK Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
12.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 426 |
Strides Pharma UK Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
291.60 |
NA |
1.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 427 |
Strides Pharma UK Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(78) |
| 428 |
Strides Pharma UK Ltd |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
6.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(79) |
| 429 |
Strides Pharma UK Ltd |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Support Service Income |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
168.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(80) |
| 430 |
Strides Pharma UK Ltd |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transaction between Wholly owned Subsidaries of the Listed Entity-Exempt from Audit Committee Approval under SEBI LODR |
0.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
Textual Information(81) |
| 431 |
Trinity Pharma (Pty) Ltd |
|
Asaco Trinity (Pty) Ltd |
|
Related party of subsidiary |
Any other transaction |
Guarantee Commission Expenses |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
3.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 432 |
Trinity Pharma (Pty) Ltd |
|
Grn Simaan |
|
Related party of subsidiary |
Any other transaction |
Guarantee Commission Expenses |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 433 |
Trinity Pharma (Pty) Ltd |
|
Grn Simaan |
|
Related party of subsidiary |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
1.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 434 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharma South Africa |
|
Related party of subsidiary |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
39.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 435 |
Trinity Pharma (Pty) Ltd |
|
K2 Medical (Pty) Ltd |
|
Related party of subsidiary |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 436 |
Trinity Pharma (Pty) Ltd |
|
Kahma Healthcare Group (Pty) Ltd |
|
Related party of subsidiary |
Any other transaction |
Guarantee Commission Expenses |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
4.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 437 |
Trinity Pharma (Pty) Ltd |
|
The Vaccine Bureau (Pty) Ltd |
|
Related party of subsidiary |
Any other transaction |
Reimbursement of Expenses incurred by |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
12.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 438 |
Trinity Pharma (Pty) Ltd |
|
Juno Pharmaceuticals (Canada) Corp. |
|
Related party of subsidiary |
Any other transaction |
Reimbursement of Expenses Incurred on Behalf |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 439 |
Strides Pharma Science Ltd |
|
Arun Kumar |
|
Key Managerial Personnel/ Director |
Any other transaction |
Sitting Fee |
5.00 |
NA |
5.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 440 |
Strides Pharma Science Ltd |
|
Strides Foundation Trust |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
CSR Expenses |
170.00 |
NA |
170.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 441 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantees or Collateral given |
0.00 |
NA |
0.00 |
17,177.50 |
16,435.40 |
|
|
|
|
|
|
|
|
|
|
| 442 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantees or Collateral Realease |
0.00 |
NA |
1,387.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 443 |
Strides Pharma Asia Pte Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantees or Collateral given |
0.00 |
NA |
0.00 |
1,688.30 |
1,862.20 |
|
|
|
|
|
|
|
|
|
|
| 444 |
Strides Pharma Asia Pte Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantees or Collateral given |
0.00 |
NA |
0.00 |
17,177.50 |
16,435.40 |
|
|
|
|
|
|
|
|
|
|
| 445 |
Strides Pharma Asia Pte Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantees or Collateral Realease |
0.00 |
NA |
1,387.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 446 |
Strides Pharma Asia Pte Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Guarantees or Collateral given |
0.00 |
NA |
0.00 |
3,262.00 |
3,598.00 |
|
|
|
|
|
|
|
|
|
|
| 447 |
Strides Arcolab International Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
9.00 |
9.30 |
|
|
|
|
|
|
|
|
|
|
| 448 |
Strides Arcolab International Ltd |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
7,079.60 |
7,999.80 |
|
|
|
|
|
|
|
|
|
|
| 449 |
Strides Arcolab International Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,423.00 |
2,107.90 |
|
|
|
|
|
|
|
|
|
|
| 450 |
Strides Arcolab International Ltd |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
(7,034.90) |
|
|
|
|
|
|
|
|
|
|
| 451 |
Strides Global Consumer Healthcare Limited |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,253.70 |
1,683.10 |
|
|
|
|
|
|
|
|
|
|
| 452 |
Strides Netherlands B.V. |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.50 |
33.20 |
|
|
|
|
|
|
|
|
|
|
| 453 |
Strides Pharma (Cyprus) Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
(75.70) |
|
|
|
|
|
|
|
|
|
|
| 454 |
Strides Pharma (Cyprus) Limited |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
230.40 |
262.90 |
|
|
|
|
|
|
|
|
|
|
| 455 |
Strides Pharma (Cyprus) Limited |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
607.60 |
33.00 |
|
|
|
|
|
|
|
|
|
|
| 456 |
Strides Pharma Asia Pte Ltd |
|
Trinity Pharma (Pty) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
22.20 |
2.00 |
|
|
|
|
|
|
|
|
|
|
| 457 |
Strides Pharma Canada Inc. |
|
Pharmapar Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
626.60 |
|
|
|
|
|
|
|
|
|
|
| 458 |
Strides Pharma Canada Inc. |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(337.40) |
(387.80) |
|
|
|
|
|
|
|
|
|
|
| 459 |
Strides Pharma Global (UK) Ltd |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(62.90) |
(61.90) |
|
|
|
|
|
|
|
|
|
|
| 460 |
Strides Pharma Global Pte Limited |
|
Amexel Pte. Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
6.80 |
1.70 |
|
|
|
|
|
|
|
|
|
|
| 461 |
Strides Pharma Global Pte Limited |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
5.00 |
|
|
|
|
|
|
|
|
|
|
| 462 |
Strides Pharma Global Pte Limited |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
4,479.30 |
4,656.40 |
|
|
|
|
|
|
|
|
|
|
| 463 |
Strides Pharma Global Pte Limited |
|
Strides Netherlands B.V. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(12.20) |
(29.80) |
|
|
|
|
|
|
|
|
|
|
| 464 |
Strides Pharma Global Pte Limited |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.90 |
|
|
|
|
|
|
|
|
|
|
| 465 |
Strides Pharma Global Pte Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(5,948.70) |
(6,394.50) |
|
|
|
|
|
|
|
|
|
|
| 466 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Asia Pte Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(1,222.50) |
(338.00) |
|
|
|
|
|
|
|
|
|
|
| 467 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,211.70 |
1,127.00 |
|
|
|
|
|
|
|
|
|
|
| 468 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(32,385.80) |
(16,583.10) |
|
|
|
|
|
|
|
|
|
|
| 469 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,673.30 |
6,615.30 |
|
|
|
|
|
|
|
|
|
|
| 470 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(5,948.70) |
66.60 |
|
|
|
|
|
|
|
|
|
|
| 471 |
Strides Pharma Global Pte Limited |
|
Strides Pharma New Zealand Pty Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.90 |
38.20 |
|
|
|
|
|
|
|
|
|
|
| 472 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Science Pty Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
14.80 |
(227.30) |
|
|
|
|
|
|
|
|
|
|
| 473 |
Strides Pharma Global Pte Limited |
|
Strides Softgels Pte Ltd |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(310.20) |
17,074.70 |
|
|
|
|
|
|
|
|
|
|
| 474 |
Strides Pharma Global Pte Limited |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(8.30) |
(33.10) |
|
|
|
|
|
|
|
|
|
|
| 475 |
Strides Pharma Global Pte Limited |
|
UCL Brands Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
13,397.40 |
|
|
|
|
|
|
|
|
|
|
| 476 |
Strides Pharma Inc |
|
Aurore Life Sciences Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 477 |
Strides Pharma Inc |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
34.40 |
35.70 |
|
|
|
|
|
|
|
|
|
|
| 478 |
Strides Pharma Inc |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
156.60 |
|
|
|
|
|
|
|
|
|
|
| 479 |
Strides Pharma Inc |
|
Naari Pharma Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.10 |
(0.60) |
|
|
|
|
|
|
|
|
|
|
| 480 |
Strides Pharma Inc |
|
Naari Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
0.60 |
|
|
|
|
|
|
|
|
|
|
| 481 |
Strides Pharma Inc |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
56.50 |
351.00 |
|
|
|
|
|
|
|
|
|
|
| 482 |
Strides Pharma Inc |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(22.50) |
1.10 |
|
|
|
|
|
|
|
|
|
|
| 483 |
Strides Pharma Inc |
|
Serovia Usa Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
0.00 |
115.60 |
|
|
|
|
|
|
|
|
|
|
| 484 |
Strides Pharma Inc |
|
Shasun Usa Inc |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
141.90 |
147.50 |
|
|
|
|
|
|
|
|
|
|
| 485 |
Strides Pharma Inc |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
16.10 |
16.70 |
|
|
|
|
|
|
|
|
|
|
| 486 |
Strides Pharma Inc |
|
Steriscience Pte Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
35.80 |
19.20 |
|
|
|
|
|
|
|
|
|
|
| 487 |
Strides Pharma Inc |
|
Strides Arcolab International Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(1.30) |
(4.00) |
|
|
|
|
|
|
|
|
|
|
| 488 |
Strides Pharma Inc |
|
Strides Consumer LLC |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
678.40 |
765.20 |
|
|
|
|
|
|
|
|
|
|
| 489 |
Strides Pharma Inc |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(22.50) |
(28.40) |
|
|
|
|
|
|
|
|
|
|
| 490 |
Strides Pharma Inc |
|
Strides Pharma International Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(2,680.60) |
(2,786.60) |
|
|
|
|
|
|
|
|
|
|
| 491 |
Strides Pharma International Limited |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(11.50) |
(15.20) |
|
|
|
|
|
|
|
|
|
|
| 492 |
SVADS Holdings SA |
|
Strides Pharma International Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
83.70 |
121.40 |
|
|
|
|
|
|
|
|
|
|
| 493 |
Strides Pharma Science Ltd |
|
Atma Projects |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
699.60 |
699.60 |
|
|
|
|
|
|
|
|
|
|
| 494 |
Strides Pharma Science Ltd |
|
Beltapharm SpA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
21.50 |
21.80 |
|
|
|
|
|
|
|
|
|
|
| 495 |
Strides Pharma Science Ltd |
|
Chayadeep Properties Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
218.80 |
204.30 |
|
|
|
|
|
|
|
|
|
|
| 496 |
Strides Pharma Science Ltd |
|
K.R. Anuradha |
|
Promoter Group |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
440.40 |
460.70 |
|
|
|
|
|
|
|
|
|
|
| 497 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
72.00 |
72.00 |
|
|
|
|
|
|
|
|
|
|
| 498 |
Strides Pharma Science Ltd |
|
Strides Consumer Private Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
157.80 |
157.70 |
|
|
|
|
|
|
|
|
|
|
| 499 |
Strides Pharma Science Ltd |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
71.40 |
80.50 |
|
|
|
|
|
|
|
|
|
|
| 500 |
Strides Pharma Science Ltd |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(81.10) |
(84.30) |
|
|
|
|
|
|
|
|
|
|
| 501 |
Strides Pharma Science Ltd |
|
Strides Pharma Canada Inc. |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(59.40) |
(63.80) |
|
|
|
|
|
|
|
|
|
|
| 502 |
Strides Pharma Science Ltd |
|
Strides Pharma Global Pte Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1,418.00 |
2,113.70 |
|
|
|
|
|
|
|
|
|
|
| 503 |
Strides Pharma Science Ltd |
|
Strides Pharma Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
244.90 |
259.60 |
|
|
|
|
|
|
|
|
|
|
| 504 |
Strides Pharma Science Ltd |
|
Strides Pharma UK Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
140.00 |
151.40 |
|
|
|
|
|
|
|
|
|
|
| 505 |
Strides Pharma Science Ltd |
|
Universal Corporation Limited |
|
Associate |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
78.10 |
81.10 |
|
|
|
|
|
|
|
|
|
|
| 506 |
Strides Pharma Science Ltd |
|
Velbiom Probiotics Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
58.60 |
58.60 |
|
|
|
|
|
|
|
|
|
|
| 507 |
Arco Lab Private Limited |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(10.10) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 508 |
Strides Arcolab International Ltd |
|
Strides Global Consumer Healthcare Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
459.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 509 |
Strides Pharma (Cyprus) Limited |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
44.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 510 |
Strides Pharma (Cyprus) Limited |
|
Strides Lifesciences Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(23.70) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 511 |
Strides Pharma Global Pte Limited |
|
Strides Pharma Global (UK) Ltd |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
277.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 512 |
Strides Pharma Inc |
|
Vensun Pharmaceuticals Inc |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
13,597.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 513 |
Strides Pharma International Limited |
|
Strides CIS Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
3.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 514 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(26,892.10) |
(5,897.40) |
|
|
|
|
|
|
|
|
|
|
| 515 |
Strides Pharma Science Ltd |
|
Onesource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(78.30) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 516 |
Strides Pharma Science Ltd |
|
Strides Pharma Asia Pte Ltd |
|
Subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
849.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 517 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
19.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 518 |
Strides CIS Limited |
|
Strides Pharma (Cyprus) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(38.10) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 519 |
Strides Netherlands B.V. |
|
Strides Nordic APS |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
85.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 520 |
SVADS Holdings SA |
|
Strides Pharma International Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
83.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 521 |
Trinity Pharma (Pty) Ltd |
|
Apollo Life Sciences Holdings (Pty) Limited |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
(3.90) |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 522 |
Strides Pharma Global Pte Limited |
|
Dr. Kausalya Santhanam |
|
Key Managerial Personnel/ Director |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 523 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Fairmed Healthcare GmbH |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
137.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 524 |
Strides Arcolab International Ltd |
|
Dr. Kausalya Santhanam |
|
Key Managerial Personnel/ Director |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 525 |
Strides Pharma Asia Pte Ltd |
|
Dr. Kausalya Santhanam |
|
Key Managerial Personnel/ Director |
Any other transaction |
Other Financial Assets/Liabilities |
0.00 |
It represents only the opening and closing balances between the entities. Audit Committee approval is not applicable. |
0.00 |
1.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 526 |
Strides Pharma UK Ltd |
|
Instapill Private Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Licencing Fee Expenses |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
134.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 527 |
Strides Pharma UK Ltd |
|
Onesource Specialty Pte. Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Licencing Fee Expenses |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
43.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 528 |
Arco Lab Private Limited |
|
Strides Pharma Services Private limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Rental Income |
0.00 |
Transactions of subsidiary with Related Party within the specified thresholds as per SEBI (LODR); Exempt from Audit committee approval |
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 529 |
Strides Pharma Global Pte Limited |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Royalty Income |
1,734.60 |
NA |
1,185.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 530 |
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
SVADS Holdings SA |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Royalty Expense |
60.10 |
NA |
12.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 531 |
Strides Pharma Science Ltd |
|
Solara Active Pharma Sciences Limited |
|
Enterprises owned or significantly influenced by key management personnel and relative of key management personnel of the listed entity |
Any other transaction |
Rental Income |
200.00 |
NA |
87.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 532 |
Strides Pharma Science Ltd |
|
Strides Pharma International AG (Formerly Fairmed Healthcare AG) |
|
Step-down subsidiary of the listed entity |
Any other transaction |
Royalty Income |
2,000.00 |
NA |
353.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
Total value of transaction during the reporting period |
2,67,946.60 |
|
|